Coronary revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: 2-year follow-up from a large multicenter registry.

Introduction: Multivessel coronary artery disease (MVD) occurs in one‑third of patients with ST‑segment elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI). However, long‑term prognosis and readmission rates in this high‑risk group remain unclear.

Objectives: We aimed to evaluate the long‑term risk of cardiovascular events and readmissions in STEMI patients with MVD.

How to treat coronary in-stent restenosis? Recent advances and their practical implications: State-of-the-Art Review.

Percutaneous coronary intervention with stent implantation has revolutionized the treatment of coronary artery disease. However, a significant drawback of this approach is the risk of in-stent restenosis (ISR), which increases each year following stent placement. This review of the current literature aims to enhance our understanding of the mechanisms behind ISR and its treatment.

The Automated Subcutaneous Implantable Cardioverter-Defibrillator Screening in Patients With Leadless Pacemakers.

Background: The number of leadless pacemakers (LPMs) implantations has seen a major growth in recent years. Indications for LPMs often overlap with indications for subcutaneous implantable cardioverter-defibrillators (sICDs), as they are mostly recommended in patients in whom transvenous devices are deemed ineligible or contraindicated. Before sICD implantation, the patient should pass screening to verify the stability of QRS morphology in intrinsic and paced rhythms.

Percutaneous coronary intervention and coronary artery bypass grafting in myocardial infarction complicated by cardiogenic shock.

Background: Cardiogenic shock (CS) remains the leading cause of poor prognosis in patients with acute myocardial infarction (AMI), sustaining a high mortality rate of 40 to 50% within 30 days.

Aims: In this unique analysis of two national all-comers, real-life registries including patients with AMI complicated by CS, for whom early revascularization was planned, we aimed to compare the effect of percutaneous coronary revascularization (PCI) and coronary artery bypass grafting (CABG) on 30-day and 1-year all-cause mortality.

Methods: The study included consecutive patients with AMI complicated by CS included in the Polish Registry of Acute Coronary Syndromes (PL-ACS) and the Polish National Registry of Cardiac Surgical Procedures (KROK), treated with PCI and CABG, respectively.

Right ventricular systolic pressure predicts outcomes in patients with cardiac resynchronization therapy defibrillators.

Background: Cardiac resynchronization therapy defibrillators (CRT-D) are a cornerstone of the treatment of heart failure and wide QRS. In such subjects, there is often concomitant right ventricular (RV) dysfunction.

Aims: We aimed to assess whether there is an association between RV function parameters and all-cause mortality or CRT-D therapies.

Position statement of Polish Cardiac Society experts on cardiomyopathy.

Cardiomyopathies (CMs) are a very broad group of diseases, including genetically determined and acquired, and their classification is based on phenotypic characteristics. There is always a need to search for the etiology (often also to try to identify the genetic cause), which may determine the appropriate choice of clinical management. The geographical distribution of genetic variants varies as does the prevalence across populations, ethnic groups, regions, and countries.

Impact of chronic total occlusion on prognosis in cardiogenic shock due to unprotected left main coronary artery culprit lesion. Insights from the Polish Registry of Acute Coronary Syndromes.

Background: Notwithstanding readily available revascularization, significant advancements in mechanical circulatory support, and pharmacological progress, cardiogenic shock (CS) secondary to unprotected left main culprit lesion-related acute myocardial infarction (ULMCL-related AMI) is associated with very high mortality. In this population, chronic total occlusion (CTO) is relatively frequent.

Aims: This study sought to assess the association between the presence of CTO and 12-month mortality in patients with CS due to ULMCL-related AMI.